XML 17 R6.htm IDEA: XBRL DOCUMENT v3.20.4
Consolidated Statements of Cash Flows (Unaudited) - USD ($)
$ in Millions
9 Months Ended
Dec. 26, 2020
Dec. 28, 2019
Cash flows from operating activities:    
Net income (loss) $ (47.0) $ 633.3
Adjustments to reconcile net income (loss) to net cash provided by operating activities:    
Depreciation and amortization expense 185.5 201.0
Deferred income tax benefit (101.8) (155.7)
Non-cash stock-based compensation expense 54.4 72.9
Non-cash impairment of assets 35.7 21.7
Bad debt expense (benefit) (20.3) 1.9
Other non-cash benefits (2.7) (0.3)
Changes in operating assets and liabilities:    
Accounts receivable (67.3) 46.9
Inventories (92.0) (89.0)
Prepaid expenses and other current assets (0.2) (30.4)
Accounts payable and accrued liabilities 346.9 56.3
Income tax receivables and payables 39.8 16.1
Deferred income 4.8 0.6
Other balance sheet changes (1.2) (27.3)
Net cash provided by operating activities 334.6 748.0
Cash flows from investing activities:    
Capital expenditures (80.8) (216.0)
Purchases of investments (512.3) (890.1)
Proceeds from sales and maturities of investments 848.0 1,510.3
Acquisitions and ventures (2.0) 0.9
Proceeds from sale of property 0.0 20.8
Settlement of net investment hedges 3.7 0.0
Net cash provided by investing activities 256.6 425.9
Cash flows from financing activities:    
Repayments of borrowings on credit facilities (475.0) 0.0
Proceeds from issuance of long-term debt 1,241.9 0.0
Repayments of long-term debt (300.0) 0.0
Payments of finance lease obligations (8.6) (10.6)
Payments of dividends (49.8) (153.2)
Repurchases of common stock, including shares surrendered for tax withholdings (36.1) (542.1)
Other financing activities (8.7) (0.9)
Net cash provided by (used in) financing activities 363.7 (706.8)
Effect of exchange rate changes on cash, cash equivalents, and restricted cash 46.8 (4.2)
Net increase in cash, cash equivalents, and restricted cash 1,001.7 462.9
Cash, cash equivalents, and restricted cash at beginning of period 1,629.8 626.5
Cash, cash equivalents, and restricted cash at end of period $ 2,631.5 $ 1,089.4